EUVIMEDEUVIMED entdecken
Crossref

Abstract 8060: PLB is a Novel Intracellular Target of Neprilysin in the Failing Human Heart

Jacob Cunningham, Taylor A Phillips, Alexis Mazzenga, Kush Nagrani, Tuan Bui, David Y Barefield, Seth L Robia

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.8060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Jacob Cunningham und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neprilysin (NEP) is a zinc-dependent metalloprotease targeted by angiotensin receptor-neprilysin inhibitors (ARNIs), which reduce mortality in heart failure with reduced ejection fraction. Clinical benefit is attributed to preservation of circulating natriuretic peptides, but NEP also localizes to the sarcoplasmic reticulum (SR), where it cleaves sarcolipin. Whether NEP cleaves phospholamban (PLB), the principal ventricular regulator of the SR Ca 2+ -ATPase (SERCA), is unknown. Hypothesis: NEP is upregulated in failing human myocardium and cleaves PLB at a C-terminal valine, disrupting SERCA regulation and contributing to Ca 2+ mishandling in heart failure (HF).

Methods

Proteomics and immunoblotting were performed on left ventricular tissue from non-failing (NF) and dilated cardiomyopathy (DCM) hearts (n=5/group). PLB-SERCA binding was quantified by FRET in HEK293T cells with or without NEP coexpression. Release of cleaved PLB from the SR membrane was assessed by saponin permeabilization and fluorescence recovery after photobleaching (FRAP). Ca 2+ transients were recorded in Fura-2-loaded neonatal rat ventricular myocytes (NRVMs) paced at 0.5 and 1 Hz. Human iPSC-derived cardiomyocytes (hiPSC-CMs) were treated with endothelin-1 (ET-1) plus or minus the NEP inhibitor sacubitrilat, with bulk RNA-sequencing.

Results

NEP was elevated 5.1-fold by mass spectrometry (adjusted P

Zitieren

APA

Cunningham, J., Phillips, T. A., Mazzenga, A., Nagrani, K., Bui, T., Barefield, D. Y., & Robia, S. L. (2026). Abstract 8060: PLB is a Novel Intracellular Target of Neprilysin in the Failing Human Heart. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.8060

Vancouver

Cunningham J, Phillips TA, Mazzenga A, Nagrani K, Bui T, Barefield DY, et al. Abstract 8060: PLB is a Novel Intracellular Target of Neprilysin in the Failing Human Heart. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.8060

BibTeX
@article{Cunningham2026,
  author = {Cunningham, Jacob and Phillips, Taylor A and Mazzenga, Alexis and Nagrani, Kush and Bui, Tuan and Barefield, David Y and Robia, Seth L},
  title = {Abstract 8060: PLB is a Novel Intracellular Target of Neprilysin in the Failing Human Heart},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.8060}
}
Kostenlos starten →